Merck, Verona Pharma have Sept. 4 US antitrust deadline
Merck and Verona Pharma have filed paperwork for their $10 billion deal with the US antitrust authorities. The initial waiting period under the Hart-Scott-Rodino Act is expected to expire on September...To view the full article, register now.
Already a subscriber? Click here to view full article